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Abstract
Screening 155 carbapenem non-susceptible Acinetobacter bauman-
nii strains recovered in Abu Dhabi hospitals identiﬁed two metal-
lo-ß-lactamase blaNDM gene-carrying isolates. They were isolated
4 months apart from the urine of a cancer patient previously
treated in Egypt, Lebanon and in the United Arab Emirates. They
were clonally related and carried the blaNDM-2 gene recently
identiﬁed in A. baumannii in Egypt and Israel. Sequences sur-
rounding the blaNDM-2 gene showed signiﬁcant similarities with
those associated with blaNDM-1 in Enterobacteriaceae and A. bau-
mannii. Repeated isolation of blaNDM-2-positive A. baumannii in
the Middle East raises the possibility of the local emergence and
spread of a unique clone.
Keywords: Acinetobacter, carbapenemase, Middle East, multidrug
resistant, NDM-2
Original Submission: 25 September 2011; Revised Submission:
7 November 2011; Accepted: 9 November 2011
Editor: R. Canto´n
Article published online: 17 November 2011
Clin Microbiol Infect 2012; 18: E34–E36
10.1111/j.1469-0691.2011.03726.x
Corresponding author: T. Pa´l, Department of Microbiology and
Immunology, Faculty of Medicine and Health Sciences, United Arab
Emirates University, PO Box 17666, Al Ain, United Arab Emirates
E-mail: tpal@uaeu.ac.ae
Enteric bacteria carrying the gene encoding the carbapenem-
ase NDM-1 have been increasingly reported worldwide. The
blaNDM-1 gene is usually located on a plasmid and its expres-
sion confers resistance to all beta-lactams except aztreonam.
Due to the frequent association with other resistance mech-
anisms, these strains are commonly multi-, or even pan-drug
resistant [1,2]. A recent study showed that the blaNDM-1
gene could easily transfer beyond the boundaries of the En-
terobacteriaceae family [3]. While the majority of species
implicated were environmental microorganisms, reports
regarding the presence of the blaNDM-1 gene in Acinetobacter
baumannii, an opportunistic pathogen causing nosocomial
outbreaks, are alarming [4]. Such strains have already been
reported from India [5], China [6] and Germany [7]. Most of
these isolates were multidrug resistant and some of them
co-expressed other carbapenemases (i.e. blaOXA-23, blaOXA-
181 and blaIMP). Recently, the NDM-2 variant (Pro to Ala sub-
stitution at position 28) was described [8]. This allele was
ﬁrst found in a multidrug-resistant A. baumannii strain iso-
lated from a German patient having previously been hospital-
ized in Egypt [8], while a subsequent one was isolated in
Israel [9]. These recent data regarding strains of Middle East-
ern origin prompted us to carry out an investigation to iden-
tify blaNDM carrying A. baumannii in the Abu Dhabi Emirate.
One hundred and 55 carbapenem non-susceptible clinical
A. baumannii isolates collected between 2008 and 2010 from
hospitals of Abu Dhabi Emirate were included in the study.
Strains were initially identiﬁed by the API20NE system (bio-
Me´rieux, Marcy l‘E´toile, France) and this was conﬁrmed by
PCR speciﬁc to the blaOXA-51-like gene [10]. Boiled extracts
of the isolates were screened by PCR for the presence of
blaNDM-1 using primers NDM1-Fo (5¢-TGCCGAGCGACTT
GGCCTTG-3¢) and NDM1-Re (5¢-ACCGATGACCAGACC
GCCCA-3¢), respectively. The reaction yielded a 379 bp-
sized amplicon of the blaNDM1 gene. Among the 155 isolates,
two blaNDM positive ones were identiﬁed. Both were recov-
ered from a 55-year old Egyptian female with a congenital
single kidney. She had been treated for a metastatic colon
carcinoma in 2004 in Egypt but due to the recurrence of the
disease in 2006 she had received subsequent treatments at
multiple centres in Cairo (Egypt), Beirut (Lebanon), Dubai
and Al Ain (UAE). In March 2008, due to a urinary obstruc-
tion from the pelvic spread of the malignancy, she underwent
surgery in Egypt with insertion of a metallic ureteric stent.
This was followed by recurrent urinary tract infections
caused by extended-spectrum ß-lactamase (ESBL)-producing
E. coli and a multidrug-resistant Pseudomonas aeruginosa trea-
ted with ceftriaxone and meropenem. In April 2009, she was
admitted to Tawam Hospital (Al Ain, UAE) because of an
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accidental dislodgement of the left solitary kidney nephrosto-
my. The ﬁrst urine culture yielded A. baumannii. During the
following months, the same strain was repeatedly isolated
from urine samples, but no antibiotics were given because
she remained afebrile and clinically stable. The two isolates
studied were from May (AG132) and August 2009 (AG124).
Both isolates exhibited the same susceptibility proﬁle
(Table 1) when tested according to CLSI standards [11].
They harboured the naturally occurring blaOXA-70 gene and
were positive for ISAba1, which was not, however, identiﬁed
upstream of the blaOXA-70 nor of the blaAmpC genes [12].
Both isolates were negative for all other carbapenemase
genes tested by PCR (i.e. blaOXA-23 [10], blaOXA-24, blaOXA-58-
like [13], blaOXA-48/-181 [14] blaVIM and blaIMP) [15]. The
strains exhibited identical pulsed-ﬁeld gel electrophoresis
patterns (data not shown) and irrespective of the methods
used they had the same multilocus sequence types ST253
[16] or ST103 [17] according to the two typing methods,
respectively. Their plasmid proﬁles were identical, with mul-
tiple plasmid bands ranging from 7- to 140-kb. Attempts to
transfer the blaNDM gene by conjugation to E. coli J53 or by
electro-transformation into E. coli J53 or into A. baumannii
BM4547 failed.
Escherichia coli DH5a was transformed with pUC19 con-
taining fragments generated by partial digestion of genomic
DNA with HindIII (New England Biolabs, Ipswich, MA, USA)
followed by plating onto plates containing 8 lg/L ceftazidime.
A clone carrying the plasmid p132LigB with an insert of c.
10 kb containing the blaNDM gene was identiﬁed (Table 1). A
3675-bp long partial sequence of the insert covering the
ﬂanking regions of blaNDM (GenBank accession number
JN112341) was generated by primer walking and subse-
quently conﬁrmed by direct, bidirectional sequencing with
primers ASndm1 (5¢-GTCGCAAAGCCCAGCTTCGCA-3¢)
and ASndm2 (5¢-GCCTCGCATTTGCGGGGTTTTTA-3¢).
Detailed sequence analysis identiﬁed blaNDM-2 [8] that did
not contain the silent A ﬁ G substitution at position 468
found in the blaNDM-2 allele described in the recent Israeli
isolate [9]. The fact that insertion sequence ISAba125 was
present upstream of the blaNDM-2 gene in this isolate as
found for the blaNDM-1 and blaNDM-2 genes in A. baumannii
and in Enterobacteriaceae suggests that it may contribute to
the dissemination of the blaNDM-like genes [7,9,18,19]. Down-
stream of blaNDM-2, the same sequences as those identiﬁed
downstream of blaNDM-1 in A. baumannii 161/07 from Ger-
many were detected [7]. Within this region, the presence of
a putative bleomycin resistance gene and a phosphoribosyl
anthralinate isomerase gene was conﬁrmed (Fig. 1.).
After the recent identiﬁcation of NDM-1-producing Klebsi-
ella pneumoniae from Sultanate of Oman [20], this study con-
stitutes another identiﬁcation of that emerging threat in the
Arabian Peninsula. Although the speciﬁc location where this
patient had been infected with this strain cannot be clearly
established, her prior hospitalization in the Middle East
where two similar strains had been recently reported [8,9]
raises the possibility of a link between all those isolates.
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TABLE 1. Antibiotic susceptibility of the strains and derivatives
MIC (mg/L) Disc diffusion
Microdilution E-test Zone diameter in mm
IMI MER CAZ CIP GM AM COL TG SAM AZT DOX CHL STX
AG132 >32 >32 >256 >32 0.125 32 0.125 0.19 18 0 12 0 0
AG124 >32 >32 >256 >32 0.125 48 0.094 0.094 23 9 12 0 0
DH5a(pUC19) £0.125 £0.125 0.19 ND ND ND ND ND ND ND ND ND ND
DH5a(p132LigB) 1 2 >256 ND ND ND ND ND ND ND ND ND ND
Antibiotic susceptibility tests were carried out by CLSI guidelines [11].
IMI, imipenem; MER, meropenem; CAZ, ceftazidime; CIP, ciproﬂoxacin; GM, gentamicin; AM, amikacin; COL, colistin; TG, tigecycline; SAM, ampicillin/sulbactam; AZT, aztreo-
nam; DOX, doxycycline; CHL, chloramphenicol; STX, trimethoprim-sulphamethoxasol; ND, not done.
ISAba125 blaNDM2 ble ȴtrpF
P
3675 bp
680 bp
FIG. 1. Genetic surrounding of blaNDM-2 in Acinetobacter baumannii
AG132. P–promoter (GenBank accession No. JN112341).
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